Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease

Abstract

The prevalence of coronary artery disease (CAD) in patients with peripheral arterial disease (PAD) has been well defined. However, the prevalence of PAD in hospitalized patients with CAD has not been defined. The ankle-brachial index (ABI) is a useful non-invasive tool to screen for PAD. The aim of our study was to assess the prevalence of PAD in hospitalized patients with CAD by measuring the ABI. The study was conducted at the University of Wisconsin Hospital and Clinics inpatient Cardiovascular Medicine Service. Medically stable patients with CAD were invited to participate prior to hospital discharge. Data regarding cardiovascular risk factors, history of previous PAD, physical examination, and ABI were collected. An ABI less than or equal to 0.9 or a history of previous lower extremity vascular invention was considered to be indicative of significant PAD. A total of 100 patients (66 men and 34 women) were recruited. Forty patients were found to have PAD (mean ABI in nonrevascularized patients with PAD = 0.67). By measuring the ABI, 37 (25 men) were positive for PAD and three had an ABI corrected with previous revascularization. Of these patients, 21 (52.5%) had previously documented PAD. Patients with PAD were older (p = 0.003), had a greater smoking history (p = 0.002), were more likely to have diabetes (p = 0.012), hypertension (p = 0.013) and a trend towards more dyslipidemia (p = 0.055). In conclusion, hospitalized patients with CAD are likely to have concomitant PAD. Risk factors for PAD in this patient population include advanced age, history of smoking, diabetes, hypertension, dyslipidemia and abnormal pulse examination. Identification of patients with PAD by measuring the ankle-brachial index is easily done.

Keywords

ankle-brachial index coronary artery disease epidemiology peripheral arterial disease prevalence

References

Dieter RS , Chu WW , Pacanowski JP , McBride PE , Tanke TE. The significance of lower extremity peripheral arterial disease. Clin Cardiol 2002; 25: 3-10.

Morbidity & M ortality: 2002 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD. National Heart, Lung, and Blood Institute, May 2002.

Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl M ed 2001; 344: 1608-1621.

Criqui MH , Fronek A , Barrett-Connor E et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 74: 510-515.

Hirsch AT , Criqui MH , Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.

Hintze J. NCSS and PASS. Kaysville, UT: Number Cruncher Statistical Systems, 2001.

Sorenson KE , Kristensen IB , Celemajer DS. Atherosclerosis in the human brachial artery. J Am Coll Cardiol 1997; 29: 318-322.

Hertzer NR. Clinical experience with preoperative coronary angiography. J Vasc Surg 1985; 2: 510-514.

Aronow WS , Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothromboticbrain infarction in men and women < 62 years of age. Am J Cardiol 1994; 74: 64-65.

10.

CAPRIE Steering Committee . A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.

11.

TASC Working Group . Management of peripheral arterial disease. J Vasc Surg 2003; 31(1 suppl): S1-S296.

12.

Murabito JM , D’ Agostino RB , Silbershatz H , Wilson PWF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 1997; 96: 44-49.

13.

Leng GC , Papacosta O , Whincup P et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis 2000; 152: 167-174.

14.

Djousse L , Levy D , Murabito JM , Cupples LA , Ellison RC Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study. Circulation 2000; 102: 3092-3097.

15.

Newman AB , Sisicovick DS , Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993; 88: 837-845.

16.

Worthley SG , Helft G , Zaman AG , Fuster V , Badimon JJ. Atherosclerosis and the vulnerable plaque-pathogenesis: Part I. Aust NZ J Med 2000; 30: 600-607.

17.

Dieter RS. Vascular adhesion molecules (letter). Contemp Surg 1998; 52(6): 374-374.

18.

McDermott MM , Feinglass J , Slavensky R , Pearce WH. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern M ed. 1994; 9: 445-449.

19.

McKenna M , Wolfson S , Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: 119-128.

20.

Wenger NK , Froelicher ES , Smith LK et al. Cardiac rehabilitation. Clinical practice guideline No. 17. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, October 1995 AHCPR Publication No. 96-0672.

21.

Criqui MH , Fronek A , Klauber MR , Barrett-Connor E , Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasice testing in a defined population. Circulation 1985; 71: 516-522.